Viridian Therapeutics, Inc.VRDNNASDAQ
LOADING
|||
Switch Symbol:
Debt to Equity Over Time
Trending lower, above historical average, structural decline.
Left:
||||
Debt-to-equity ratio
Latest
0.03
↑ 116% above average
Average (9y)
-0.20
Historical baseline
Range
High:0.53
Low:-3.21
CAGR
-12.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 0.03 | -34.0% |
| 2023 | 0.05 | +257.8% |
| 2022 | 0.01 | +380.5% |
| 2021 | 0.00 | -26.9% |
| 2020 | 0.00 | -99.3% |
| 2019 | 0.53 | +162.8% |
| 2018 | 0.20 | -22.2% |
| 2017 | 0.26 | +108.0% |
| 2016 | -3.21 | -3119.9% |
| 2015 | 0.11 | - |